Longenesis

Longenesis
Longenesis
Longenesis is a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those of need.

Longenesis was established in 2019 with a clear goal – to transform a traditional process of conducting biomedical research. They have developed a tool for identification of stakeholders for further collaboration, SaaS digital patient consent management tool and disease-specific tools for patients/population cohorts proactive engagement in clinical research activities. In just 3 years of existence, the company has initiated a collaboration with 20+ biomedical institutions, as well as patient organizations, biobanks, genomic sequencers, clinics and health authorities in the U.S., South Korea, Northern European region, and the Middle East.

Riga
BioTech, Research, Healthcare, Digital Health
No funding announced yet
2019

Articles about Longenesis:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Longenesis? We’re happy to assist you with our Startup Sourcing service.